课题基金 / 基金详情

Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability

Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability
针对微卫星不稳定性肿瘤移码突变特征的疫苗的制备
批准号：
10329725
负责人：
Beth Tebeau
金额：
$15.94万
依托单位：
ADVANCED BIOSCIENCE LABORATORIES, INC.
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
项目状态：
已结题
起止时间：
2019-09-19 至 2021-05-06
来源：
https://reporter.nih.gov/project-details/10329725
关键词：
AddressAdjuvantAnnual ReportsBackCharacteristicsChemistryClinical TrialsContractorCyclic GMPDataDocumentationFrameshift MutationFreeze DryingGuidelinesHealthInjectionsInternationalInvestigational DrugsInvestigational New Drug ApplicationMarketingMethodsMicrosatellite InstabilityPeptidesPerformancePharmaceutical PreparationsPhasePreparationRecordsReportingScheduleServicesSterilityTestingToxicologyVaccinesVial deviceWaterWorkanalytical methodauthoritybasedrug testingmeetingsnovel therapeuticsreconstitutionrepositoryresearch and developmentresearch clinical testingresponsestability testingsymposiumtumor

项目摘要

项目成果

Beth Tebeau的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this task order is to acquire research & development services in support of the project, “Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability”, through the tasks identified in the Statement of Work dated 5/20/2019.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability
Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability
海外基金